These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 998633)

  • 1. Double-blind evaluation of 5-mum final filtration to reduce postinfusion phlebitis.
    Evans WE; Barker LF; Simone JV
    Am J Hosp Pharm; 1976 Nov; 33(11):1160-3. PubMed ID: 998633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filtration and infusion phlebitis: a double-blind prospective clinical study.
    DeLuca PP; Rapp RP; Bivins B; McKean HE; Griffen WO
    Am J Hosp Pharm; 1975 Oct; 32(10):1001-7. PubMed ID: 1103617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of filtration on complications of postoperative intravenous therapy.
    Rusho WJ; Bair JN
    Am J Hosp Pharm; 1979 Oct; 36(10):1355-6. PubMed ID: 507079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inline filtration on postinfusion phlebitis.
    Maddox RR; John JF; Brown LL; Smith CE
    Clin Pharm; 1983; 2(1):58-61. PubMed ID: 6883931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticulate-induced phlebitis. Its prevention by in-line filtration.
    Falchuk KH; Peterson L; McNeil BJ
    N Engl J Med; 1985 Jan; 312(2):78-82. PubMed ID: 3880597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing superficial phlebitis during infusion of crystalloid solutions in surgical patients.
    Bass J; Freeman JB; Makarewicz P; Sproule P; Fairfull-Smith R
    Can J Surg; 1985 Mar; 28(2):124-5. PubMed ID: 3971235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final inline filtration: a means of decreasing the incidence of infusion phlebitis.
    Bivins BA; Rapp RP; DeLuca PP; McKean H; Griffen WO
    Surgery; 1979 Apr; 85(4):388-94. PubMed ID: 432800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinfusion phlebitis and in-line terminal membrane filtration.
    Thayssen P; Kortegaard N; Winding O
    Dan Med Bull; 1977 Sep; 24(4):160-2. PubMed ID: 336303
    [No Abstract]   [Full Text] [Related]  

  • 10. Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis.
    Schroeder HG; DeLuca PP
    Am J Hosp Pharm; 1976 Jun; 33(6):543-6. PubMed ID: 1274972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inline filtration of intravenous infusions on the incidence of thrombophlebitis.
    Chamberland ME; Lyons RW; Brock SM
    Am J Hosp Pharm; 1977 Oct; 34(10):1068-70. PubMed ID: 920740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postinfusion phlebitis after intravenous push versus intravenous piggyback administration of antimicrobial agents.
    Garrelts JC; Ast D; LaRocca J; Smith DF; Peterie JD
    Clin Pharm; 1988 Oct; 7(10):760-5. PubMed ID: 3233896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postinfusion phlebitis associated with a syringe system versus minibags.
    Rapp RP; Powers P; Tolbert V; Piecoro JJ; Record KE
    Clin Pharm; 1986 May; 5(5):408-11. PubMed ID: 3720211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final in-line filtration: removal of contaminants from IV fluids and drugs.
    Rapp RP; Bivins BA
    Hosp Formul; 1983 Dec; 18(12):1124-8. PubMed ID: 10264358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparinization of alimentation solutions administered through peripheral veins in premature infants: a controlled study.
    Alpan G; Eyal F; Springer C; Glick B; Goder K; Armon J
    Pediatrics; 1984 Sep; 74(3):375-8. PubMed ID: 6433319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices.
    Hamilton RA; Plis JM; Clay C; Sylvan L
    Clin Pharm; 1988 Jun; 7(6):439-43. PubMed ID: 3402178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral intravenous therapy-related phlebitis rates in an adult population.
    White SA
    J Intraven Nurs; 2001; 24(1):19-24. PubMed ID: 11836840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling intermittent injection sites.
    Epperson EL
    Clin Pharm; 1984; 3(6):626-9. PubMed ID: 6509875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.